The biobank provides biological samples from cancer patients who have provided their consent for joint research, also with companies. October 28, 2016
RIKEN team finds new transcription starting point of hepatitis B virus
HBV is a major cause of liver cancer, and nearly 700,00 people per year are estimated to die from this disease. A team around Piero Carnici at RIKEN has created a detailed transcription map down to one base unit analyzing the gene expression pattern of the virus and discovered a new transcription starting point, which […]
Luna Japan obtains permission functionality labelling of Bifidobacterium HN019 in yoghurt
The strain was developed by Danisco, now a Dupont company, and is claimed to improve the intestinal environment and improve fitness. Marketing is done by Luna Japan, a joint venture of Nippon Ham and Dupont. Nikkei Biotech news release, October 28, 2016
Astellas acquires German Ganymed Pharmceuticals, an antibody specialist
Ganymed (CEO Dr. Özlem Türeci) is a biopharmaceutical company located in Mainz, Germany, which focuses on the development of antibodies against cancer. Under the contract, Astellas will pay EUR 422 million to acquire 100% of the equity in Ganymed. In addition, Ganymed’s shareholders will become eligible to receive up to EUR 860 million in further […]